So 3Q09 is in the rear view mirror and out dribbles the August 2009 Trend Analysis - the temporal delay is indeed embarrassing however, believe it or not the September 2009 OnBioVC Trend Analysis is hot on the heels and will be available in a few days. Focusing back on August for the moment there was a total of $528.7M invested across 29 deals. To date over $4,341M has flowed into early-stage biopharma, diagnostic and device companies, keep up with all of the financings in the August 2009 OnBioVC Trend Analysis Available [HERE].
________________________________________________________________________

Sign up [HERE] for FREE Subscription to ‘Pharmaceutical Executive’ and ‘Life Science Leader’ Magazines (and other journals too!)